News & Blog

Aspen Neuroscience Chief Financial Officer Kameel Farag to Present at Upcoming Investor Conferences

Aspen Neuroscience Announces Dosing Completion of First Cohort in ASPIRO Phase 1/2a Trial for Parkinson’s Disease

ProJenX and Unlearn Announce Partnership to Augment ALS Clinical Trial PRO-101 with Digital Twin Model

Endpoints News: Stem cell startup spun out of George Church’s lab raises $75M

BioPharma Dive: Startup from George Church’s lab raises $75M to develop ‘supercell’ medicines

FierceBiotech: From ‘science fiction to reality’: New George Church-founded biotech raises $75M for cell therapy platform

STAT: A new cell therapy company takes its vision from four founders, and its skin from George Church

GC Therapeutics Launches to Scale and Unlock the Next Generation of Cell Therapy

MEC in Q2 2024

Truvian: Independent Study Highlights Robustness and Ease-of-Use of Truvian’s Blood Testing Platform in a Real-World Clinical Setting